Prospective external validation of biomarkers to predict acute graft-versus-host disease severity

Acute graft-versus-host disease (GVHD) is still the major contributor to comorbidities and mortality after allogeneic hematopoietic stem cell transplantation. The use of plasmatic biomarkers to predict early outcomes has been advocated in the past decade. The purpose of this prospective nonintervent...

Descripción completa

Detalles Bibliográficos
Autores principales: Robin, Marie, Porcher, Raphael, Michonneau, David, Taurines, Laetitia, de Fontbrune, Flore Sicre, Xhaard, Aliénor, Oriano, Bastien, Sutra Del Galy, Aurélien, Peffault de Latour, Régis, Socié, Gérard, Schlageter, Marie-Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631673/
https://www.ncbi.nlm.nih.gov/pubmed/35667096
http://dx.doi.org/10.1182/bloodadvances.2022007477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631673/
https://www.ncbi.nlm.nih.gov/pubmed/35667096
http://dx.doi.org/10.1182/bloodadvances.2022007477

Ejemplares similares